New York, New York 10010

  • Related Disorders


The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid dependence.

Study summary:

The objective of this study is to determine the safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment.


Inclusion Criteria: DSM-IV diagnosis of current opiate dependence males and non-pregnant, non-nursing female 18-59 yrs of age Exclusion Criteria: Any significant medical condition AST or ALT levels greater than 3x's the upper limit of normal level Current Axis I diagnosis other than opiate, caffeine or nicotine dependence



Primary Contact:

Principal Investigator
John Rotrosen, M.D.
New York MDRU

Backup Contact:


Location Contact:

New York, New York 10010
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: April 03, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.